Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis

Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis

Sepsis is a life-threatening condition caused by an abnormal immune response induced by infection with no approved or specific therapeutic options. We present our perspectives for the therapeutic management of sepsis through a four-way approach: (1) infection control through immune enhancement; (2)...

Full description

Bibliographic Details
Main Authors:	Senthilkumar Preethy, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Surya Prakash, Nobunao Ikewaki, Yasunori Ikeue, Mitsuru Nagataki, Masaru Iwasaki, Rajappa Senthilkumar, Samuel J. K. Abraham
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Immunology
Subjects:	immune-modulation COVID-19 biological response modifier beta-glucans sepsis immune-paralysis immune cell ratios
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.870632/full

Similar Items

Beneficial immune-regulatory effects of novel strains of Aureobasidium pullulans AFO-202 and N-163 produced beta glucans in Sprague Dawley rats
by: Nobunao Ikewaki, et al.
Published: (2021-12-01)

Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
by: Kadalraja Raghavan, et al.
Published: (2023-12-01)

Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19
by: Nobunao Ikewaki, et al.
Published: (2021-03-01)

Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study
by: Kadalraja Raghavan, et al.
Published: (2022-09-01)

Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
by: Kadalraja Raghavan, et al.
Published: (2023-12-01)

β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
by: Nobunao Ikewaki, et al.
Published: (2021-08-01)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
by: Naoki Yamamoto, et al.
Published: (2022-07-01)

Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements
by: Kosagi-Sharaf Rao, et al.
Published: (2020-07-01)

Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan
by: Nobunao Ikewaki, et al.
Published: (2020-10-01)

β-Glucan in invertebrates
by: V Vetvicka, et al.
Published: (2004-11-01)

b-Glucan in invertebrates
by: V Vetvicka, et al.
Published: (2004-11-01)

Autologous Immune Enhancement Therapy in Recurrent Ovarian Cancer with Metastases: A Case Report
by: Sadananda Rao Manjunath, et al.
Published: (2012-01-01)

β-Glucan and parasites
by: Vetvicka V., et al.
Published: (2018-09-01)

β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs
by: Simon Paris, et al.
Published: (2020-10-01)

Development of Fish Immunity and the Role of β-Glucan in Immune Responses
by: Marianna V. Rodrigues, et al.
Published: (2020-11-01)

Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression
by: Vaclav Vetvicka, et al.
Published: (2021-03-01)

Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan
by: Senthilkumar Preethy, et al.
Published: (2023-10-01)

Vaccination with Recombinant <italic toggle="yes">Cryptococcus</italic> Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species
by: Charles A. Specht, et al.
Published: (2017-12-01)

IMMUNOMODULATING PROPERTIES OF THE PLANT GLUCANS AT EXPERIMENTAL IMMUNODEPRESSION
by: V. B. Khobrakova, et al.
Published: (2012-11-01)

Immunomodulatory Effect and Biological Significance of β-Glucans
by: Xuemei Zhong, et al.
Published: (2023-05-01)

Systemic administration of β-glucan of 200 kDa modulates melanoma microenvironment and suppresses metastatic cancer
by: Mei Zhang, et al.
Published: (2018-02-01)

Immune-enhancing effect of water-soluble beta-glucan derived from enzymatic hydrolysis of yeast glucan
by: Yingji Xin, et al.
Published: (2022-07-01)

Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review
by: Valeria Cognigni, et al.
Published: (2021-04-01)

β-glucans from Agaricus bisporus mushroom products drive Trained Immunity
by: Sarah Case, et al.
Published: (2024-02-01)

Targeting β-glucans, vital components of the Pneumocystis cell wall
by: Mengyan Wang, et al.
Published: (2023-02-01)

Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials
by: Vaclav Vetvicka, et al.
Published: (2019-03-01)

Cross-Protection Induced by Encephalitis Vaccines against COVID-19 Might be a Reason for Relatively Lower Mortality Rate in Some Countries
by: Shojiro Katoh, et al.
Published: (2020-04-01)

<i>Euglena gracilis</i> β-Glucans (1,3): Enriching Colostrum of Sow for Enhanced Piglet Immunity
by: Rafael Humberto de Carvalho, et al.
Published: (2023-11-01)

The Modulating Effect of Dietary Beta-Glucan Supplementation on Expression of Immune Response Genes of Broilers during a Coccidiosis Challenge
by: Islam I. Omara, et al.
Published: (2021-01-01)

Shaping the Innate Immune Response by Dietary Glucans: Any Role in the Control of Cancer?
by: Manuela Del Cornò, et al.
Published: (2020-01-01)

Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles
by: Mei Zhang, et al.
Published: (2018-02-01)

Oral supplementation with yeast β-glucans improves the resolution of Escherichia coli-associated inflammatory responses independently of monocyte/macrophage immune training
by: Sarah Walachowski, et al.
Published: (2022-12-01)

Systemic administration of β-glucan induces immune training in microglia
by: Yang Heng, et al.
Published: (2021-02-01)

β-Glucans from Yeast—Immunomodulators from Novel Waste Resources
by: Scintilla Thomas, et al.
Published: (2022-05-01)

Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
by: Anne Geller, et al.
Published: (2020-07-01)

β-glucans: a potential source for maintaining gut microbiota and the immune system
by: Ravindra Pal Singh, et al.
Published: (2023-05-01)

Chemical Structure and Immune Activation of a Glucan From Rhizoma Acori Tatarinowii
by: Wuxia Zhang, et al.
Published: (2022-06-01)

The influence of dietary β-glucans on the adaptive and innate immune responses of European sea bass (Dicentrarchus labrax) vaccinated against vibriosis
by: Pier Paolo Gatta, et al.
Published: (2010-01-01)

Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages
by: Bart G. J. Moerings, et al.
Published: (2021-06-01)

Glutathione Metabolism Is a Regulator of the Acute Inflammatory Response of Monocytes to (1→3)-β-D-Glucan
by: Rayoun Ramendra, et al.
Published: (2021-11-01)